CELANESE CORP

Member Only Articles

AI Health Factor Performance Trends

Latest Insights

20 February, 2025
Celanese Faces Mixed Analyst Opinions Amid Significant Quarterly Loss and Revenue Decline
Read More >>
19 February, 2025
Celanese Faces Mixed Analyst Opinions Amid Significant Quarterly Loss and Revenue Decline
Celanese Corporation has been under intense scrutiny from analysts recently, reflecting concerns about its financial health and market performance. As of now, the company’s 12-month average price targ...
Read More
17 February, 2025
Celanese Corporation Faces Multiple Investigations Over Disappointing Earnings and Stock Plunge Amid Allegations of Misleading Information
Celanese Corporation is currently embroiled in multiple investigations concerning potential violations of federal securities laws following a disappointing earnings report released on November 4, 2024...
Read More
16 February, 2025
Celanese Corporation Faces Multiple Investigations Over Disappointing Earnings and Stock Plunge Amid Allegations of Misleading Information
Celanese Corporation is currently embroiled in multiple investigations concerning potential violations of federal securities laws following a disappointing earnings report released on November 4, 2024...
Read More
15 February, 2025
Investigations Launched Against Celanese Corporation Over Allegations of Misleading Investors After Significant Stock Drop
Celanese Corporation is currently facing multiple investigations following its disappointing third-quarter earnings announcement on November 4, 2024, which disclosed a 26.3% plunge in stock value. Thi...
Read More

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.